Multifocal neurotoxicity during interleukin-2 therapy for malignant melanoma
- 1 January 1992
- journal article
- case report
- Published by Elsevier in Clinical Oncology
- Vol. 4 (2) , 135-136
- https://doi.org/10.1016/s0936-6555(05)80990-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Acute Fatal Leukoencephalopathy after Interleukin-2 TherapyNew England Journal of Medicine, 1990
- Lymphocyte migration into brain modelled in vitro: Control by lymphocyte activation, cytokines, and antigenCellular Immunology, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury.The Journal of Immunology, 1988
- Malignant melanoma and central nervous system metastases.Incidence, diagnosis, treatment and survivalCancer, 1978